eFFECTOR Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $33,844,000.
Profit Margin
| 2019 | 0 | -29.73M | |
|---|---|---|---|
| 2020 | 42M | 14.21M | 33.84% |
| 2021 | 1.43M | 15.79M | 1104.76% |
| 2022 | 3.55M | -12.92M | -363.83% |
| 2023 | 0 | -35.81M |
EFTRW Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 3.55M | 1.43M | 42M | 0 |
Cost of revenue | 22.91M | 53K | 24K | 21.83M | 307K |
Gross profit | -22.91M | 3.5M | 1.40M | 20.16M | -307K |
Operating exp. | |||||
Research and development | 22.91M | 23.31M | 19.95M | 21.83M | 23.58M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 33.84M | 32.40M | 31.89M | 26.18M | 28.29M |
Operating income | -33.84M | -32.40M | -31.89M | 15.81M | -28.60M |
Other income (expenses), net | -1.96M | 9.73M | 47.69M | -1.25M | -1.13M |
Income before tax | -35.81M | -22.66M | 15.79M | 14.56M | -29.73M |
Income tax expense | 0 | -9.73M | -24K | 351K | 0 |
Net income | -35.81M | -12.92M | 15.79M | 14.21M | -29.73M |
Earnings per share | |||||
Basic EPS | -16.37 | -7.85 | 9.78 | 23.74 | -53.83 |
Diluted EPS | -16.37 | -7.85 | 9.78 | 23.74 | -53.83 |
| Data source | Data source | Data source | Data source |